BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34516963)

  • 1. Lung Cancer Screening in a Safety-Net Hospital: Rare Harms Inform Decision Making.
    Lutzow LK; Magarinos J; Dass C; Ma GX; Erkmen CP
    Ann Thorac Surg; 2022 Oct; 114(4):1168-1175. PubMed ID: 34516963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying Benefits and Harms of Lung Cancer Screening in an Underserved Population: Results From a Prospective Study.
    Erkmen CP; Randhawa S; Patterson F; Kim R; Weir M; Ma GX
    Semin Thorac Cardiovasc Surg; 2022; 34(2):691-700. PubMed ID: 34091014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"?
    Nishi SPE; Lowenstein LM; Mendoza TR; Lopez Olivo MA; Crocker LC; Sepucha K; Niu J; Volk RJ
    Chest; 2021 Jul; 160(1):330-340. PubMed ID: 33556362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world lung cancer screening decision-making: Barriers and facilitators.
    Lowenstein M; Vijayaraghavan M; Burke NJ; Karliner L; Wang S; Peters M; Lozano A; Kaplan CP
    Lung Cancer; 2019 Jul; 133():32-37. PubMed ID: 31200824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
    Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
    Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs.
    Lowenstein LM; Deyter GMR; Nishi S; Wang T; Volk RJ
    Transl Lung Cancer Res; 2018 Jun; 7(3):254-271. PubMed ID: 30050764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual- and neighborhood-level characteristics of lung cancer screening participants undergoing telemedicine shared decision making.
    Shusted CS; Juon HS; Ruane B; Till B; Zeigler-Johnson C; McIntire RK; Grenda T; Okusanya O; Evans NR; Kane GC; Barta JA
    BMC Health Serv Res; 2023 Oct; 23(1):1179. PubMed ID: 37899430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Enhanced Shared Decision Making Model to Address Willingness and Ability to Undergo Lung Cancer Screening and Follow-Up Treatment in Minority Underserved Populations.
    Erkmen CP; Mitchell M; Randhawa S; Sferra S; Kim R; DiSesa V; Kaiser LR; Ma GX
    J Community Health; 2018 Feb; 43(1):27-32. PubMed ID: 28612174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Shared Decision Making for Lung Cancer Screening.
    Brenner AT; Malo TL; Margolis M; Elston Lafata J; James S; Vu MB; Reuland DS
    JAMA Intern Med; 2018 Oct; 178(10):1311-1316. PubMed ID: 30105393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the information needs of lung cancer screening participants: a qualitative study.
    Ruparel M; Quaife S; Baldwin D; Waller J; Janes S
    BMJ Open Respir Res; 2019; 6(1):e000448. PubMed ID: 31803474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring shared decision-making needs in lung cancer screening among high-risk groups and health care providers in China: a qualitative study.
    Lin X; Wang F; Li Y; Lei F; Chen W; Arbing RH; Chen WT; Huang F
    BMC Cancer; 2024 May; 24(1):613. PubMed ID: 38773461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When Is a Harm a Harm? Discordance between Patient and Medical Experts' Evaluation of Lung Cancer Screening Attributes.
    Schapira MM; Rodriguez KL; Chhatre S; Fraenkel L; Bastian LA; Kravetz JD; Asan O; Akers S; Vachani A; Prigge JM; Meline J; Ibarra JV; Corn B; Kaminstein D
    Med Decis Making; 2021 Apr; 41(3):317-328. PubMed ID: 33554740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study.
    Braithwaite D; Karanth SD; Slatore CG; Zhang D; Bian J; Meza R; Jeon J; Tammemagi M; Schabath M; Wheeler M; Guo Y; Hochhegger B; Kaye FJ; Silvestri GA; Gould MK
    BMJ Open; 2022 Jun; 12(6):e064142. PubMed ID: 35732383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization as an opportunity to engage underserved individuals in shared decision-making for lung cancer screening: results from two randomized pilot trials.
    Kathuria H; Gunawan A; Spring M; Aijaz S; Cobb V; Fitzgerald C; Wakeman C; Howard J; Clancy M; Foreman AG; Truong V; Wong C; Steiling K; Lasser KE; Bulekova K; Wiener RS
    Cancer Causes Control; 2022 Nov; 33(11):1373-1380. PubMed ID: 35997854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Lung Cancer Screening Program Websites.
    Clark SD; Reuland DS; Enyioha C; Jonas DE
    JAMA Intern Med; 2020 Jun; 180(6):824-830. PubMed ID: 32282024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Incidental Findings Information on Lung Cancer Screening Intent: a Randomized Controlled Trial.
    Clark SD; Reuland DS; Brenner AT; Jonas DE
    J Gen Intern Med; 2022 Nov; 37(14):3676-3683. PubMed ID: 35113322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Health-Care Organizations Implement Shared Decision-making When It Is Required for Reimbursement: The Case of Lung Cancer Screening.
    Alishahi Tabriz A; Neslund-Dudas C; Turner K; Rivera MP; Reuland DS; Elston Lafata J
    Chest; 2021 Jan; 159(1):413-425. PubMed ID: 32798520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.
    Pinsky PF; Bellinger CR; Miller DP
    J Med Screen; 2018 Jun; 25(2):110-112. PubMed ID: 28929865
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.